Sanofi to produce synthetic antimilarial drugs
French drug maker Sanofi has announced the launch of a new commercial-scale manufacturing process to develop tons of artemisinin, the […]
Tags: biology, california, drug maker, Garessio, health, Health/Medical/Pharmaceuticals, Institute for OneWorld Health, Italy, malaria, manufacturing process, medicine, melinda gates foundation, PATH president and CEO, SANOFI S.A., Semisynthesis, supply chain, treatment for malaria, United States, University of California, USD
Action Plan to Halt Malaria Drug Resistance
The United Nations health agency launched a new action plan to halt the spread of resistance to artemisinin, the world’s most potent treatment for malaria, warning that the tremendous gains made in recent years against the disease are under threat.
